|
|
||||||||




* Department of Medicine III, RWTH University Hospital Aachen, Aachen,
Department of Internal Medicine I, University of Regensburg, Regensburg, and
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; and
Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom
IL-6 is known to play a crucial role in the pathogenesis of chronic intestinal inflammation by modulating T cell functions. In this study, we investigated the role of gp130, the common signal transducer for all IL-6 cytokines, in a murine model of acute T cell independent colitis to better characterize the impact of gp130 on innate immune cells and the early stages of inflammation. Experimental colitis was induced by dextran sulfate sodium treatment of mice with inducible systemic deletion of gp130 (MxCre/gp130–/–), macrophage/neutrophil-specific gp130-deficiency (LysCre/gp130–/–), or bone marrow chimeric mice and compared with wild-type controls (gp130f/f). Systemic deletion of gp130 (MxCre/gp130–/–) protected mice from severe colitis and wasting and attenuated the mucosal inflammatory infiltrate as well as local cytokine, chemokine, and adhesion molecule expression. Experiments in newly generated macrophage/neutrophil-specific gp130-deleted animals (LysCre/gp130–/–) and gp130 bone marrow chimeric mice, revealed a dual mechanism of proinflammatory effects mediated by gp130. Leukocyte recruitment was impaired in gp130-deleted animals and gp130-deleted recipients of wild-type bone marrow, demonstrating a central role of gp130-dependent signals in nonmyeloid cells for directing leukocytes to sites of inflammation, which was further confirmed in a model of sterile peritonitis. In contrast, macrophage/neutrophil-specific gp130 deficiency delayed and attenuated the disease but only marginally affected the inflammatory infiltrate, indicating a defective activation of mucosal leukocytes. We provide evidence that IL-6 cytokines acting via gp130 are required in the acute stages of intestinal inflammation by modulating the dynamics of innate immune cell recruitment and activation.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by the University of Aachen, Rheinisch Westphälische Technische Hochschule (START Grant 690634 to L.E.S.) and the Deutsche Forschungsgemeinschaft (SFB 542-C14 to C.T., DFG Ta 434/2-1 to F.T., and DFG Ob 135/10-1 to F.O.).
2 Address correspondence and reprint requests to Prof. Christian Trautwein, Department of Medicine III, University Hospital of Aachen, University of Aachen (RWTH), Pauwelsstrasse 30, 52074 Aachen, Germany. E-mail address: ctrautwein{at}ukaachen.de
3 Abbreviations used in this paper: IBD, inflammatory bowel disease; DAI, disease activity index; DSS, dextran sulfate sodium; WBC, white blood cell; wt, wild type; tg, transgenic.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |